United States· US:73650-316_65969ac7-9258-473d-bb73-7572428703ab
TZIELD
A teplizumab product containing teplizumab, registered in United States by Provention Bio, Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Teplizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC A10XX01 (teplizumab), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Teplizumab · ATC A10XX01
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TEPLIZUMAB
- Manufacturer
- Provention Bio, Inc.
- Country
- United States (US)
- ATC code
- A10XX01
- ATC class
- Teplizumab
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 1
- ndc1173650-316-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Teplizumab in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTEIZEILDSanofi Winthrop Industrie, Gentilly
- SpainTEIZEILD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONSanofi Winthrop Industrie
- FinlandTeizeildSanofi Winthrop Industrie
- FranceTEIZEILD 1 mg/1 mL, solution à diluer pour perfusionSANOFI WINTHROP INDUSTRIE
- United KingdomTzield 2mg/2ml concentrate for solution for infusion vialsSanofi
- BelgiumTeizeild 1 mg/mlSanofi Winthrop Industrie
- IcelandTeizeildSanofi Winthrop Industrie
- NetherlandsTeizeild 1 mg/ml concentraat voor oplossing voor infusieSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Teizeild
- Liechtenstein · Teizeild
- Norway · Teizeild
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/87fc059c-6a8f-448d-86dd-686a8b4e4535 GET /v1/drugs/87fc059c-6a8f-448d-86dd-686a8b4e4535?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "1",
"substance": "TEPLIZUMAB",
"productndc": "73650-316",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "BLA761183",
"marketing_category": "BLA"
}See everything about teplizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.